SCHEMBL1344504

SCHEMBL1344504

CCOC(=O)C(CC)C(Cc1ccc(OC)cc1)c1ccc(OC)cc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 2/20 0.44
▸ LDHA P00338 1/20 0.42
▸ KMT2A Q03164 3/20 0.41
▸ GLA P06280 1/20 0.41
▸ PPARG P37231 2/20 0.41
▸ PRKCZ Q05513 1/20 0.39
▸ GAA P10253 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ CCR6 P51684 1/20 0.37
▸ HKDC1 Q2TB90 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ KLK7 P49862 1/20 0.36
▸ TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1344851 0.81 EPHX2 (0.53) EPHX2LDHAKMT2AGLAPPARG
SCHEMBL1345038 0.81 LDHA (0.42) EPHX2LDHAPPARGALDH1A1KDM4E
Hydrochloric Acid SCHEMBL21332000 0.74 PRKCZ (0.45) KMT2AGLAPRKCZALDH1A1TDP1
SCHEMBL5040727 0.74 PRKCZ (0.44) KMT2AGLAPRKCZGAAALDH1A1
SCHEMBL5040728 0.74 PRKCZ (0.44) KMT2AGLAPRKCZGAAALDH1A1
SCHEMBL10982437 0.73 ESR1 (0.47) EPHX2KMT2AGLAALDH1A1TDP1
SCHEMBL21342326 0.73 PRKCZ (0.46) KMT2AGLAPRKCZALDH1A1TDP1
SCHEMBL20581292 0.72 ALDH1A1 (0.45) KMT2APPARGPRKCZALDH1A1TDP1
SCHEMBL20581295 0.72 ALDH1A1 (0.45) KMT2APPARGPRKCZALDH1A1TDP1
SCHEMBL14874381 0.72 MMP8 (0.46) EPHX2KMT2APPARGGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406206-B1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES MSD OSS BV (NL) 2013-01-30 — — EP disclosed
EP-2406206-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES MSD Oss B.V. (NL) 2012-01-18 — — EP disclosed
US-8063102-B2 Tetrahydronaphthalen-2-ol derivatives N.V. ORGANON (NL) 2011-11-22 — — US disclosed
US-20100240748-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES N. V. ORGANON 2010-09-23 — — US disclosed
WO-2010103095-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES N.V. ORGANON (NL) 2010-09-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240748-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES VHL, BRCA1, TPH2 EPHX2 1099/4885LDHA 995/4885KMT2A 1554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback